PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.
- DOI
- 10.1093/carcin/bgl236
- Published
- 2007 May
- Container
- Carcinogenesis
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/carcin/bgl236,
title = {PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.},
author = {Lai J and Kedda MA and Hinze K and Smith RL and Yaxley J and Spurdle AB and Morris CP and Harris J and Clements JA},
year = {2007},
journal = {Carcinogenesis},
doi = {10.1093/carcin/bgl236},
url = {https://doi.org/10.1093/carcin/bgl236}
}RIS
TY - JOUR TI - PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility. AU - Lai J AU - Kedda MA AU - Hinze K AU - Smith RL AU - Yaxley J AU - Spurdle AB AU - Morris CP AU - Harris J AU - Clements JA PY - 2007 JO - Carcinogenesis DO - 10.1093/carcin/bgl236 UR - https://doi.org/10.1093/carcin/bgl236 ER -
APA
J, L., MA, K., K, H., RL, S., J, Y., AB, S., CP, M., J, H., & JA, C. (2007). PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.. Carcinogenesis. https://doi.org/10.1093/carcin/bgl236
Source records
- pubmed · retrieved 2026-09-25T10:17:50.812Z